Government officials and insurers should consider improving coverage for all type 1 diabetes–related services, following the approach of a 2019 rule allowing qualified high-deductible health plans to cover services such as insulin and glucometers before deductibles are met.5 This evidence concerns the gene INS and type 1 diabetes mellitus.